Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1227

1.

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.

Ganzel C, Wang XV, Rowe JM, Richards SM, Buck G, Marks DI, Litzow MR, Paietta EM, Foroni L, Luger SM, Willman CL, Mullighan CG, Roberts KG, Wiernik PH, Douer D, Lazarus HM, Tallman MS, Goldstone AH.

Br J Haematol. 2020 Mar 27. doi: 10.1111/bjh.16616. [Epub ahead of print]

PMID:
32220069
2.

Health Insurance Coverage of Permanent Hair Removal in Transgender and Gender-Minority Patients.

Thoreson N, Marks DH, Peebles JK, King DS, Dommasch E.

JAMA Dermatol. 2020 Mar 25. doi: 10.1001/jamadermatol.2020.0480. [Epub ahead of print]

PMID:
32211825
3.

Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative.

Anthias C, Apperley J, Bloor A, Byrne J, Collin M, Crawley C, Craddock C, Finnegan D, Gilleece M, Gribben J, Hunter A, Hunter H, Koh M, Mackinnon S, Malladi R, Marks D, McQuaker G, Nikolousis M, Orchard K, Pavlu J, Peniket A, Potter M, Potter V, Robinson S, Russell N, Salim R, Snowden J, Thomson K, Tholouli E, Wilson K.

Bone Marrow Transplant. 2020 Mar 24. doi: 10.1038/s41409-020-0870-0. [Epub ahead of print] No abstract available.

PMID:
32210353
4.

Lymphocyte activation gene (LAG)-3 is associated with mucosal inflammation and disease activity in ulcerative colitis.

Slevin SM, Garner LC, Lahiff C, Tan M, Wang LM, Ferry H, Greenaway B, Lynch K, Geremia A, Hughes S, Leavens K, Krull D, Marks DJB, Nevin K, Page K, Srinivasan N, Tarzi R, Klenerman P, Travis S, Arancibia-Cárcamo CV, Keshav S.

J Crohns Colitis. 2020 Mar 16. pii: jjaa054. doi: 10.1093/ecco-jcc/jjaa054. [Epub ahead of print]

PMID:
32179884
5.

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.

Lee CJ, Kim S, Tecca HR, Bo-Subait S, Phelan R, Brazauskas R, Buchbinder D, Hamilton BK, Battiwalla M, Majhail NS, Lazarus HM, Shaw PJ, Marks DI, Litzow MR, Chhabra S, Inamoto Y, DeFilipp Z, Hildebrandt GC, Olsson RF, Kasow KA, Liesveld JL, Rotz SJ, Badawy SM, Bhatt NS, Yared JA, Page KM, Arellano ML, Kent M, Farhadfar N, Seo S, Hematti P, Freytes CO, Rovó A, Ganguly S, Nathan S, Burns L, Shaw BE, Muffly LS.

Blood Adv. 2020 Mar 24;4(6):983-992. doi: 10.1182/bloodadvances.2019001126.

6.

Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy: Guidelines for Hematopoietic Transplantation and Cellular Therapy.

Kanate AS, Majhail NS, Savani BN, Bredeson C, Champlin RE, Crawford S, Giralt SA, LeMaistre CF, Marks DI, Omel JL, Orchard PJ, Palmer J, Saber W, Veys PA, Carpenter PA, Hamadani M.

Biol Blood Marrow Transplant. 2020 Mar 9. pii: S1083-8791(20)30114-2. doi: 10.1016/j.bbmt.2020.03.002. [Epub ahead of print]

PMID:
32165328
7.

Structural coordination of polymerization and crosslinking by a SEDS-bPBP peptidoglycan synthase complex.

Sjodt M, Rohs PDA, Gilman MSA, Erlandson SC, Zheng S, Green AG, Brock KP, Taguchi A, Kahne D, Walker S, Marks DS, Rudner DZ, Bernhardt TG, Kruse AC.

Nat Microbiol. 2020 Mar 9. doi: 10.1038/s41564-020-0687-z. [Epub ahead of print]

PMID:
32152588
8.

Difficult posteroseptal pathway ablation and recurrent PSVT.

Marks D, Knight BP, Verma N.

J Cardiovasc Electrophysiol. 2020 Mar 5. doi: 10.1111/jce.14434. [Epub ahead of print] No abstract available.

PMID:
32141119
9.

Androgenetic Alopecia in Gender Minority Patients.

Marks DH, Senna MM.

Dermatol Clin. 2020 Apr;38(2):239-247. doi: 10.1016/j.det.2019.10.010. Epub 2019 Nov 26. Review.

PMID:
32115134
10.

Skin Cancer and Skin Cancer Risk Factors in Sexual and Gender Minorities.

Marks DH, Arron ST, Mansh M.

Dermatol Clin. 2020 Apr;38(2):209-218. doi: 10.1016/j.det.2019.10.005. Epub 2019 Nov 23. Review.

PMID:
32115130
11.

Recent Advances in the Management of Acute Lymphoblastic Leukaemia.

Hodby KA, Marks DI.

Curr Treat Options Oncol. 2020 Feb 20;21(3):23. doi: 10.1007/s11864-020-0712-8. Review.

PMID:
32095902
12.

Acute Lymphoblastic Leukemia in Adults.

Stelljes M, Marks DI.

In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 71.

13.

Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic cancer.

Burfeind KG, Zhu X, Norgard MA, Levasseur PR, Huisman C, Michaelis KA, Olson B, Marks DL.

Glia. 2020 Feb 10. doi: 10.1002/glia.23796. [Epub ahead of print]

PMID:
32039522
14.

Not all (N)SAID and done: Effects of nonsteroidal anti-inflammatory drugs and paracetamol intake on platelets.

Driver B, Marks DC, van der Wal DE.

Res Pract Thromb Haemost. 2019 Nov 26;4(1):36-45. doi: 10.1002/rth2.12283. eCollection 2020 Jan. Review.

15.

The Lipid Composition of Platelets and the Impact of Storage: An Overview.

Green SM, Padula MP, Marks DC, Johnson L.

Transfus Med Rev. 2020 Jan 8. pii: S0887-7963(20)30002-X. doi: 10.1016/j.tmrv.2019.12.001. [Epub ahead of print] Review.

PMID:
31987597
16.

Traditional Growing Rod Graduates of Different Etiologic Categories have Similar Clinical and Radiographic Outcomes.

Akbarnia B, Pawelek J, Hosseini P, Salari P, Kabirian N, Marks D, Shah SA, Skaggs D, Emans J, Hazem E, Thompson G, Sponseller P.

Spine Deform. 2019 Nov;7(6):1015-1016. doi: 10.1016/j.jspd.2019.09.037. No abstract available.

PMID:
31974970
17.

Patch testing and contact allergen avoidance in patients with lichen planopilaris and/or frontal fibrosing alopecia: A cohort study.

Prasad S, Marks DH, Burns LJ, De Souza B, Flynn EA, Scheinman P, Silvestri D, Yu J, LoSicco K, Senna MM.

J Am Acad Dermatol. 2020 Jan 19. pii: S0190-9622(20)30077-3. doi: 10.1016/j.jaad.2020.01.026. [Epub ahead of print] No abstract available.

PMID:
31962088
18.

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma.

Gartrell-Corrado RD, Chen AX, Rizk EM, Marks DK, Bogardus MH, Hart TD, Silverman AM, Bayan CY, Finkel GG, Barker LW, Komatsubara KM, Carvajal RD, Horst BA, Chang R, Monod A, Rabadan R, Saenger YM.

Cancer Res. 2020 Mar 1;80(5):1078-1087. doi: 10.1158/0008-5472.CAN-19-2039. Epub 2020 Jan 16.

PMID:
31948941
19.

Polarization-selective waveguide holography in the visible spectrum.

Huang Z, Marks DL, Smith DR.

Opt Express. 2019 Nov 25;27(24):35631-35645. doi: 10.1364/OE.27.035631.

PMID:
31878732
20.

King's College London's enquiry into Hans J Eysenck's 'Unsafe' publications must be properly completed.

Marks DF, Buchanan RD.

J Health Psychol. 2020 Jan;25(1):3-6. doi: 10.1177/1359105319887791. Epub 2019 Dec 16.

PMID:
31841048
21.

Protein Structure from Experimental Evolution.

Stiffler MA, Poelwijk FJ, Brock KP, Stein RR, Riesselman A, Teyra J, Sidhu SS, Marks DS, Gauthier NP, Sander C.

Cell Syst. 2020 Jan 22;10(1):15-24.e5. doi: 10.1016/j.cels.2019.11.008. Epub 2019 Dec 11.

22.

Training Executive, Attention, and Motor Skills (TEAMS): a Preliminary Randomized Clinical Trial of Preschool Youth with ADHD.

Halperin JM, Marks DJ, Chacko A, Bedard AC, O'Neill S, Curchack-Lichtin J, Bourchtein E, Berwid OG.

J Abnorm Child Psychol. 2020 Mar;48(3):375-389. doi: 10.1007/s10802-019-00610-w.

PMID:
31834588
23.

Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris.

Marks DH, Prasad S, De Souza B, Burns LJ, Senna MM.

Am J Clin Dermatol. 2019 Dec 12. doi: 10.1007/s40257-019-00493-z. [Epub ahead of print] Review.

PMID:
31832993
24.

Validation of the Philadelphia Mindfulness Scale on experienced meditators and nonmeditators.

Morgan MC, Cardaciotto L, Moon S, Marks D.

J Clin Psychol. 2020 Apr;76(4):725-748. doi: 10.1002/jclp.22907. Epub 2019 Dec 11.

PMID:
31825100
25.

Development of Lichen Planopilaris-Like Alopecia following Occupational Exposure to Trichloroethylene and Tetrachloroethylene.

Marks DH, Hagigeorges D, Manatis-Lornell AJ, Foreman RK, Senna MM.

Skin Appendage Disord. 2019 Nov;5(6):374-378. doi: 10.1159/000501173. Epub 2019 Jul 26.

PMID:
31799267
26.

Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.

McCleary-Wheeler AL, Carr RM, Palmer SR, Smyrk TC, Allred JB, Almada LL, Tolosa EJ, Lamberti MJ, Marks DL, Borad MJ, Molina JR, Qi Y, Lingle WL, Grothey A, Pitot HC, Jatoi A, Northfelt DW, Bryce AH, McWilliams RR, Okuno SH, Haluska P, Kim GP, Colon-Otero G, Lowe VJ, Callstrom MR, Ma WW, Bekaii-Saab T, Hung MC, Erlichman C, Fernandez-Zapico ME.

Pancreatology. 2020 Jan;20(1):101-109. doi: 10.1016/j.pan.2019.11.011. Epub 2019 Nov 21.

PMID:
31787526
27.

Freezing expired platelets does not compromise in vitro quality: An opportunity to maximize inventory potential.

Johnson L, Waters L, Green S, Wood B, Marks DC.

Transfusion. 2020 Mar;60(3):454-459. doi: 10.1111/trf.15616. Epub 2019 Nov 29.

PMID:
31782799
28.

How many serial sections are needed to detect apoptosis in endoscopic biopsies with gastrointestinal graft versus host disease?

Wong NA, Marks DI.

J Clin Pathol. 2019 Nov 22. pii: jclinpath-2019-206310. doi: 10.1136/jclinpath-2019-206310. [Epub ahead of print]

PMID:
31757782
29.

Sleeping sound with autism spectrum disorder (ASD): study protocol for an efficacy randomised controlled trial of a tailored brief behavioural sleep intervention for ASD.

Papadopoulos N, Sciberras E, Hiscock H, Williams K, McGillivray J, Mihalopoulos C, Engel L, Fuller-Tyszkiewicz M, Bellows ST, Marks D, Howlin P, Rinehart N.

BMJ Open. 2019 Nov 19;9(11):e029767. doi: 10.1136/bmjopen-2019-029767.

30.

Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.

Michaelis KA, Norgard MA, Zhu X, Levasseur PR, Sivagnanam S, Liudahl SM, Burfeind KG, Olson B, Pelz KR, Ramos DMA, Maurer HC, Olive KP, Coussens LM, Morgan TK, Marks DL.

Nat Commun. 2019 Nov 15;10(1):5257. doi: 10.1038/s41467-019-13151-z.

31.

Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research.

Buchbinder D, Brazauskas R, Bo-Subait K, Ballen K, Parsons S, John T, Hahn T, Sharma A, Steinberg A, D'Souza A, Kumar AJ, Yoshimi A, Wirk B, Shaw B, Freytes C, LeMaistre C, Bredeson C, Dandoy C, Almaguer D, Marks DI, Szwajcer D, Hale G, Schouten H, Hashem H, Schoemans H, Murthy HS, Lazarus HM, Cerny J, Tay J, Yared JA, Adekola K, Schultz KR, Lehmann L, Burns L, Aljurf M, Diaz MA, Majhail N, Farhadfar N, Kamble R, Olsson R, Schears R, Seo S, Beattie S, Chhabra S, Savani BN, Badawy S, Ganguly S, Ciurea S, Marino S, Gergis U, Kuwatsuka Y, Inamoto Y, Khera N, Hashmi S, Wood W, Saber W.

Biol Blood Marrow Transplant. 2020 Mar;26(3):553-561. doi: 10.1016/j.bbmt.2019.11.003. Epub 2019 Nov 11.

PMID:
31726205
32.

The Effect of Glucose Levels Prior to Hematopoietic Cell Transplantation on Post-Transplant Complications and Health Resource Utilization.

Steinberg A, Van Cleave JH, Parikh AB, Moshier E, Ru M, Lawson M, Marks D, Montelibano A, Philpott A, Garner K, Hammer MJ.

Int J Hematol Oncol Stem Cell Res. 2019 Jul 1;13(3):122-131.

33.

Not all red cell concentrate units are equivalent: international survey of processing and in vitro quality data.

Shih AW, Apelseth TO, Cardigan R, Marks DC, Bégué S, Greinacher A, de Korte D, Seltsam A, Shaz BH, Wikman A, Barty RL, Heddle NM, Acker JP; QMiP Investigators on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Vox Sang. 2019 Nov;114(8):783-794. doi: 10.1111/vox.12836. Epub 2019 Oct 22.

PMID:
31637738
34.

The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.

Michaelis KA, Norgard MA, Zhu X, Levasseur PR, Sivagnanam S, Liudahl SM, Burfeind KG, Olson B, Pelz KR, Angeles Ramos DM, Maurer HC, Olive KP, Coussens LM, Morgan TK, Marks DL.

Nat Commun. 2019 Oct 15;10(1):4682. doi: 10.1038/s41467-019-12657-w. Erratum in: Nat Commun. 2019 Nov 15;10(1):5257.

35.

Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use data.

Lecat CSY, Besley C, Hough RE, Khwaja A, Furness C, Marks DI, Fielding AK.

Leuk Lymphoma. 2020 Feb;61(2):491-493. doi: 10.1080/10428194.2019.1672057. Epub 2019 Oct 3. No abstract available.

PMID:
31580171
36.

Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.

Zinter MS, Logan BR, Fretham C, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, Copelan E, Duncan C, Gale RP, Guinan E, Hematti P, Keating AK, Marks DI, Olsson R, Savani BN, Ustun C, Williams KM, Pasquini MC, Dvorak CC.

Biol Blood Marrow Transplant. 2020 Feb;26(2):333-342. doi: 10.1016/j.bbmt.2019.09.027. Epub 2019 Sep 26.

PMID:
31563573
37.

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Lazaryan A, Dolan M, Zhang MJ, Wang HL, Kharfan-Dabaja MA, Marks DI, Bejanyan N, Copelan E, Majhail NS, Waller EK, Chao N, Prestidge T, Nishihori T, Kebriaei P, Inamoto Y, Hamilton B, Hashmi SK, Kamble RT, Bacher U, Hildebrandt GC, Stiff PJ, McGuirk J, Aldoss I, Beitinjaneh AM, Muffly L, Vij R, Olsson RF, Byrne M, Schultz KR, Aljurf M, Seftel M, Savoie ML, Savani BN, Verdonck LF, Cairo MS, Hossain N, Bhatt VR, Frangoul HA, Abdel-Azim H, Al Malki M, Munker R, Rizzieri D, Khera N, Nakamura R, Ringdén O, van der Poel M, Murthy HS, Liu H, Mori S, De Oliveira S, Bolaños-Meade J, Elsawy M, Barba P, Nathan S, George B, Pawarode A, Grunwald M, Agrawal V, Wang Y, Assal A, Castillo Caro P, Kuwatsuka Y, Seo S, Ustun C, Politikos I, Lazarus HM, Saber W, Sandmaier BM, De Lima M, Litzow M, Bachanova V, Weisdorf D; Acute Leukemia Committee of the CIBMTR.

Haematologica. 2019 Sep 26. pii: haematol.2019.220756. doi: 10.3324/haematol.2019.220756. [Epub ahead of print]

38.

Excess hair, hair removal methods, and barriers to care in gender minority patients: A survey study.

Marks DH, Hagigeorges D, Manatis-Lornell AJ, Dommasch E, Senna MM.

J Cosmet Dermatol. 2019 Sep 25. doi: 10.1111/jocd.13164. [Epub ahead of print]

PMID:
31553137
39.

A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.

Kebriaei P, Hayes J, Daly A, Uberti J, Marks DI, Soiffer R, Waller EK, Burke E, Skerrett D, Shpall E, Martin PJ.

Biol Blood Marrow Transplant. 2019 Sep 7. pii: S1083-8791(19)30573-7. doi: 10.1016/j.bbmt.2019.08.029. [Epub ahead of print]

PMID:
31505228
40.

Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.

Michaelis KA, Norgard MA, Levasseur PR, Olson B, Burfeind KG, Buenafe AC, Zhu X, Jeng S, McWeeney SK, Marks DL.

Brain Behav Immun. 2019 Nov;82:338-353. doi: 10.1016/j.bbi.2019.09.004. Epub 2019 Sep 6.

41.

Histologic and clinical cross-sectional study of chronic hair loss in patients with cutaneous chronic graft-versus-host disease.

Marks DH, Naftulin JS, Penzi LR, Manatis-Lornell A, Yasuda MR, Chapman CM, Rao SR, Saavedra A, Senna MM.

J Am Acad Dermatol. 2019 Nov;81(5):1134-1141. doi: 10.1016/j.jaad.2019.03.031. Epub 2019 Aug 24.

PMID:
31454500
42.

Burden of hospitalization in acute lymphoblastic leukemia patients treated with Inotuzumab Ozogamicin versus standard chemotherapy treatment.

Marks DI, van Oostrum I, Mueller S, Welch V, Vandendries E, Loberiza FR, Böhme S, Su Y, Stelljes M, Kantarjian HM.

Cancer Med. 2019 Oct;8(13):5959-5968. doi: 10.1002/cam4.2480. Epub 2019 Aug 22.

43.

Interaction specificity of clustered protocadherins inferred from sequence covariation and structural analysis.

Nicoludis JM, Green AG, Walujkar S, May EJ, Sotomayor M, Marks DS, Gaudet R.

Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):17825-17830. doi: 10.1073/pnas.1821063116. Epub 2019 Aug 20.

44.

Emerging Nonsteroid-Based Procedural Therapies for Alopecia Areata: A Systematic Review.

Marchitto MC, Qureshi A, Marks D, Awosika O, Rengifo-Pardo M, Ehrlich A.

Dermatol Surg. 2019 Dec;45(12):1484-1506. doi: 10.1097/DSS.0000000000002053.

PMID:
31403534
45.

Cause or cure? Review of dupilumab and alopecia areata.

Marks DH, Mesinkovska N, Senna MM.

J Am Acad Dermatol. 2019 Jun 13. pii: S0190-9622(19)30973-9. doi: 10.1016/j.jaad.2019.06.010. [Epub ahead of print] No abstract available.

PMID:
31391150
46.

Serum growth factor stability in different eye drop packaging systems during storage.

Tan JCG, Webb RG, Marks DC.

Transfus Apher Sci. 2019 Jul 9:102608. doi: 10.1016/j.transci.2019.06.032. [Epub ahead of print]

PMID:
31320279
47.

Comorbidities in patients with lichen planopilaris: A retrospective case-control study.

Manatis-Lornell A, Okhovat JP, Marks DH, Hagigeorges D, Senna MM.

J Am Acad Dermatol. 2019 Jul 12. pii: S0190-9622(19)32375-8. doi: 10.1016/j.jaad.2019.07.018. [Epub ahead of print] No abstract available.

PMID:
31306727
48.

Utility of laboratory testing in patients with female pattern hair loss.

Okhovat JP, Marks DH, Manatis-Lornell A, Hagigeorges D, Senna MM.

J Am Acad Dermatol. 2019 Jul 12. pii: S0190-9622(19)32372-2. doi: 10.1016/j.jaad.2019.07.015. [Epub ahead of print] No abstract available.

PMID:
31306723
49.

A randomized, controlled pilot clinical trial of cryopreserved platelets for perioperative surgical bleeding: the CLIP-I trial (Editorial, p. 2759).

Reade MC, Marks DC, Bellomo R, Deans R, Faulke DJ, Fraser JF, Gattas DJ, Holley AD, Irving DO, Johnson L, Pearse BL, Royse AG, Wong J; Cryopreserved vs Liquid Platelet (CLIP) Investigators, the Australian and New Zealand College of Anaesthetists Clinical Trials Network, and the Australian and New Zealand Intensive Care Society Clinical Trials Group.

Transfusion. 2019 Sep;59(9):2794-2804. doi: 10.1111/trf.15423. Epub 2019 Jul 10.

PMID:
31290573
50.

The role of neuraminidase 1 and 2 in glycoprotein Ibα-mediated integrin αIIbβ3 activation.

van der Wal DE, Davis AM, Mach M, Marks DC.

Haematologica. 2019 Jul 4. pii: haematol.2019.215830. doi: 10.3324/haematol.2019.215830. [Epub ahead of print]

Supplemental Content

Support Center